NO924835D0 - Fremgangsmaate ved fremstilling av dobbelt-inhibitorer forno-syntetase og cyklooksygenase - Google Patents

Fremgangsmaate ved fremstilling av dobbelt-inhibitorer forno-syntetase og cyklooksygenase

Info

Publication number
NO924835D0
NO924835D0 NO924835A NO924835A NO924835D0 NO 924835 D0 NO924835 D0 NO 924835D0 NO 924835 A NO924835 A NO 924835A NO 924835 A NO924835 A NO 924835A NO 924835 D0 NO924835 D0 NO 924835D0
Authority
NO
Norway
Prior art keywords
forno
cycloxygenase
synthetase
procedure
preparation
Prior art date
Application number
NO924835A
Other languages
English (en)
Other versions
NO302943B1 (no
NO924835L (no
Inventor
Pierre-Etienne Cha Lassauniere
Pierre Braquet
Colette Broquet
Serge Auvin
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO924835D0 publication Critical patent/NO924835D0/no
Publication of NO924835L publication Critical patent/NO924835L/no
Publication of NO302943B1 publication Critical patent/NO302943B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • C07C211/04—Mono-, di- or tri-methylamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO924835A 1992-01-04 1992-12-14 Forbindelser som er dobbelt-inhibitorer for NO-syntase og cyklooksygenase NO302943B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929200114A GB9200114D0 (en) 1992-01-04 1992-01-04 Dual inhibitors of no synthase and cyclooxygenase

Publications (3)

Publication Number Publication Date
NO924835D0 true NO924835D0 (no) 1992-12-14
NO924835L NO924835L (no) 1993-07-05
NO302943B1 NO302943B1 (no) 1998-05-11

Family

ID=10708115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924835A NO302943B1 (no) 1992-01-04 1992-12-14 Forbindelser som er dobbelt-inhibitorer for NO-syntase og cyklooksygenase

Country Status (34)

Country Link
US (2) US5480999A (no)
JP (1) JP2984498B2 (no)
KR (1) KR100287539B1 (no)
AT (1) AT401054B (no)
AU (1) AU664399B2 (no)
BE (1) BE1006227A3 (no)
CA (1) CA2085555C (no)
CH (1) CH685629A5 (no)
DE (1) DE4244539B4 (no)
DK (1) DK157592A (no)
DZ (1) DZ1657A1 (no)
ES (1) ES2052452B1 (no)
FI (1) FI925883A (no)
FR (2) FR2685916B1 (no)
GB (2) GB9200114D0 (no)
GR (1) GR1001443B (no)
HK (1) HK22296A (no)
HU (1) HU220218B (no)
IE (1) IE71675B1 (no)
IT (1) IT1256761B (no)
LU (1) LU88208A1 (no)
MA (1) MA22753A1 (no)
MY (1) MY109846A (no)
NL (1) NL194889C (no)
NO (1) NO302943B1 (no)
NZ (1) NZ245499A (no)
OA (1) OA10050A (no)
PL (1) PL169432B1 (no)
PT (1) PT101165B (no)
RU (1) RU2104999C1 (no)
SE (1) SE511568C2 (no)
TN (1) TNSN93001A1 (no)
TW (1) TW267152B (no)
ZA (1) ZA9210080B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759027B1 (en) * 1994-05-07 1999-08-04 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
EP0758890B1 (en) * 1994-05-11 2005-03-30 Jes Olesen Use of no scavengers, inhibitors or antagonists in the treatment of migraine
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
CA2132690A1 (en) * 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
DE793646T1 (de) 1994-11-23 1999-12-30 Pharmacia & Upjohn Co., Kalamazoo Carboxylierte aminoguanidine zum behandlung von insulin-unabhängigem diabetes mellitus
JPH08333258A (ja) 1994-12-14 1996-12-17 Japan Tobacco Inc チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
ES2096524B1 (es) * 1994-12-22 1997-11-16 Sanchez Manuel Guerra Uso de la ng-monometil-l-arginina, para aumentar la capacidad de hacer ejercicio fisico.
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
GB9514518D0 (en) * 1995-07-15 1995-09-13 Sod Conseils Rech Applic Guanidine salt inhibitors of NO synthase and cyclooxygenase
CN1212620A (zh) * 1996-03-05 1999-03-31 儿童医院医疗中心 作为环氧酶抑制剂的巯基衍生物
AU3117497A (en) 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
DK1255544T3 (da) * 2000-01-31 2007-09-17 Genaera Corp Mucin-syntese-inhibitorer
US7345051B2 (en) * 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
US7163958B2 (en) * 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US7244753B2 (en) * 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
MXPA05006954A (es) * 2002-12-26 2005-09-22 Pozen Inc Formas de dosificacion de capas multiples que contienen nsaids y triptanos.
AU2004247076A1 (en) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition comprising triptans and NSAIDs
AU2004249775A1 (en) * 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors
WO2005002293A2 (en) * 2003-06-25 2005-01-06 Vanderbilt University Cox-2-targeted imaging agents
US7491744B2 (en) * 2004-04-26 2009-02-17 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
MX2007008156A (es) * 2005-01-04 2007-07-24 Novartis Ag Estructura de rayos-x de la fpps humana, y uso para seleccionar compuestos que se enlazan a fpps.
US7736624B2 (en) * 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
EP3078374B1 (en) 2011-10-17 2019-06-19 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
TWM469254U (zh) 2013-08-29 2014-01-01 J D Components Co Ltd 自行車之三件式豎管

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6838M (no) * 1967-12-08 1969-03-31
ES423794A1 (es) * 1974-03-01 1976-05-01 Medicinales S A Promesa Prod Procediemiento de obtencion de una nueva sal soluble de acido acetilsalicilico.
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127274B (it) * 1979-12-04 1986-05-21 Selvi & C Spa Sali dell'acido 5-fluoro-2-metil-1-(p-(metilsulfinil)-benzilidene)-indene-3-acetico
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
CA1213888A (en) * 1983-09-28 1986-11-12 Warner-Lambert Company L-arginine isoxicamate
US5081184A (en) * 1985-08-02 1992-01-14 General Electric Company Solvent-resistant, compatible blends of polyphenylene ethers and linear polyesters
JPS6393718A (ja) * 1986-10-07 1988-04-25 Green Cross Corp:The 注射剤
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
ATE128452T1 (de) * 1989-10-17 1995-10-15 Merck & Co Inc S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth

Also Published As

Publication number Publication date
FI925883A (fi) 1993-07-05
NO302943B1 (no) 1998-05-11
TW267152B (no) 1996-01-01
GB2263111A (en) 1993-07-14
US5480999A (en) 1996-01-02
ATA256092A (de) 1995-10-15
KR100287539B1 (ko) 2001-04-16
PT101165A (pt) 1994-02-28
SE511568C2 (sv) 1999-10-18
ES2052452B1 (es) 1995-02-01
OA10050A (fr) 1996-10-14
MY109846A (en) 1997-08-30
CA2085555A1 (en) 1993-07-05
IE922954A1 (en) 1993-07-14
AU3049892A (en) 1993-07-08
PL169432B1 (pl) 1996-07-31
ITMI922953A1 (it) 1994-06-23
NL9300001A (nl) 1993-08-02
GB2263111B (en) 1995-08-16
PT101165B (pt) 1999-09-30
FR2685869B1 (fr) 1995-06-09
LU88208A1 (fr) 1993-04-15
MA22753A1 (fr) 1993-07-01
GR1001443B (el) 1993-12-30
ES2052452A1 (es) 1994-07-01
NZ245499A (en) 1995-07-26
TNSN93001A1 (fr) 1994-03-17
CA2085555C (en) 2004-07-20
AT401054B (de) 1996-06-25
DZ1657A1 (fr) 2002-02-17
DK157592D0 (da) 1992-12-30
SE9203825L (sv) 1993-07-05
CH685629A5 (fr) 1995-08-31
FR2685916A1 (fr) 1993-07-09
JPH05286916A (ja) 1993-11-02
RU2104999C1 (ru) 1998-02-20
JP2984498B2 (ja) 1999-11-29
HK22296A (en) 1996-02-16
IT1256761B (it) 1995-12-15
NL194889B (nl) 2003-02-03
GB9200114D0 (en) 1992-02-26
FR2685869A1 (fr) 1993-07-09
KR930016389A (ko) 1993-08-26
ZA9210080B (en) 1993-08-02
BE1006227A3 (fr) 1994-06-14
HU9204173D0 (en) 1993-04-28
IE71675B1 (en) 1997-02-26
DE4244539B4 (de) 2006-10-26
US5360925A (en) 1994-11-01
AU664399B2 (en) 1995-11-16
FI925883A0 (fi) 1992-12-28
GB9227026D0 (en) 1993-02-17
NO924835L (no) 1993-07-05
SE9203825D0 (sv) 1992-12-18
PL297247A1 (en) 1993-09-06
HU220218B (hu) 2001-11-28
FR2685916B1 (fr) 2001-09-28
HUT64047A (en) 1993-11-29
DE4244539A1 (no) 1993-07-08
NL194889C (nl) 2003-06-04
DK157592A (da) 1993-07-05

Similar Documents

Publication Publication Date Title
NO924835L (no) Fremgangsmaate ved fremstilling av dobbelt-inhibitorer forno-syntetase og cyklooksygenase
NO933240L (no) Anordning ved og fremstilling av tannbörste
AU4915796A (en) Inhibitors of prenyl transferases
AU6178894A (en) Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
AU4267293A (en) Use of MMP inhibitors
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
DK0832065T3 (da) Substituerede N-(indol-2-carbonyl)glycinamider og derivater som glycogenphosphorylaseinhibitorer
EP1009415A4 (en) INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES
FI962218A (fi) H2-pitoisen kaasun valmistaminen
NO995077L (no) Fremgangsmåte ved anvendelse av cyklooksygenase-2 inhibitorer
NO943353D0 (no) Kombinasjoner av ACE-inhibitorer og diuretiske midler
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
EP0666849A4 (en) ARYL AND HETEROARYL METHOXYPHENYL INHIBITORS OF LEUKOTRIA BIOSYNTHESIS.
NO973680D0 (no) Fremgangsmåte for fremstilling av ikke-vandige dispersjoner og deres anvendelse
NO944872D0 (no) Partikulært sprengstoff, fremgangsmåte ved dets fremstilling og anvendelse av sprengstoffet
DK0623614T3 (da) 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase
NO975634D0 (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
EP0657451A3 (en) Pyrrolidine derivatives as inhibitors of leukotrienic biosynthesis.
NO307547B1 (no) Anvendelse av en eosinofil kjemotaksishemmende forbindelse
AU673961B2 (en) Methods of inhibiting the effects of amyloidogenic proteins
IL128031A0 (en) Pyranoindole and carbazole inhibitors of cox-2
NO922340D0 (no) Fr, og fremgangsmaate for aa optimalisere effekten av pigmenter i for for salmonider
NO950033D0 (no) Integrering av telemetri og sonarteknologi
NO174249C (no) Fremgangsmåte ved enkelthudbygging av fartöy